Literature DB >> 14574010

Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations.

P Peltomäki1, X Gao, J P Mecklin.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is a multi-organ cancer syndrome associated with heritable mutations in DNA mismatch repair genes, particularly MLH1 (MutL Homologue 1) and MSH2 (MutS Homologue 2). We took advantage of the unique characteristics of the Finnish HNPCC families to assess genotype- phenotype correlations in this disorder. We studied 295 mutation carriers (10 mutations in MLH1 and 3 in MSH2) segregating in 55 families. In addition to the comparison of families with different mutations, the enrichment of two MLH1 mutations, one affecting exon 16 (29 families, 186 individuals) and another one affecting exon 6 (10 families, 45 individuals) allowed the comparison of kindreds with identical predisposing mutations. Extracolonic cancers were more common in MSH2 than MLH1 mutation carriers, with the ratios of 0.48 and 0.64, respectively, of colorectal cancer to all cancers (P = 0.076). Within MLH1, two mutations affecting only the amino terminal portion showed a significant association with late onset of cancer as compared to the remaining mutations. Importantly, families with the MLH1 exon 16 mutation displayed significant variation (P = 0.012) in the age at onset of colon cancer, despite shared predisposition. We conclude that even though characteristics of the inherited mutations may explain part of the observed clinical variation, other factors have a significant impact on HNPCC phenotype determination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 14574010     DOI: 10.1023/a:1011564720772

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

1.  Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds.

Authors:  M Nyström-Lahti; M Holmberg; P Fidalgo; R Salovaara; A de la Chapelle; J Jiricny; P Peltomäki
Journal:  Genes Chromosomes Cancer       Date:  1999-12       Impact factor: 5.006

2.  Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction.

Authors:  K Aktan-Collan; J P Mecklin; H Järvinen; M Nyström-Lahti; P Peltomäki; I Söderling; A Uutela; A de la Chapelle; H Kääriäinen
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

3.  Population-based molecular detection of hereditary nonpolyposis colorectal cancer.

Authors:  R Salovaara; A Loukola; P Kristo; H Kääriäinen; H Ahtola; M Eskelinen; N Härkönen; R Julkunen; E Kangas; S Ojala; J Tulikoura; E Valkamo; H Järvinen; J P Mecklin; L A Aaltonen; A de la Chapelle
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

4.  Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer.

Authors:  S Guerrette; T Wilson; S Gradia; R Fishel
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

5.  A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype.

Authors:  N C Nicolaides; S J Littman; P Modrich; K W Kinzler; B Vogelstein
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer.

Authors:  A L Moisio; P Sistonen; J Weissenbach; A de la Chapelle; P Peltomäki
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer.

Authors:  G Moslein; D J Tester; N M Lindor; R Honchel; J M Cunningham; A J French; K C Halling; M Schwab; P Goretzki; S N Thibodeau
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

8.  Cancer family "G" revisited: 1895-1970.

Authors:  H T Lynch; A J Krush
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

9.  Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair.

Authors:  C Ban; M Junop; W Yang
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

10.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  25 in total

1.  Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters.

Authors:  M M Blokhuis; G E Pietersen; P A Goldberg; U Algar; L Van der Merwe; N Mbatani; A A Vorster; R S Ramesar
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

2.  Detection of germline mutations of hMLH1 and hMSH2 based on cDNA sequencing in China.

Authors:  Chao-Fu Wang; Xiao-Yan Zhou; Tai-Ming Zhang; Meng-Hong Sun; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

3.  Genetics and pathology of pancreatic cancer.

Authors:  Jordan M Winter; Anirban Maitra; Charles J Yeo
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 4.  Lynch syndrome genes.

Authors:  Päivi Peltomäki
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population.

Authors:  Yuan-Zhi Zhang; Jian-Qiu Sheng; Shi-Rong Li; Hong Zhang
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

6.  Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.

Authors:  Miklós Tanyi; Judith Olasz; Géza Lukács; Orsolya Csuka; László Tóth; Zoltán Szentirmay; Zsuzsa Ress; Zsolt Barta; János L Tanyi; László Damjanovich
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria.

Authors:  Katie A Ashton; Cliff J Meldrum; Mary L McPhillips; Janina Suchy; Grzegorz Kurzawski; Jan Lubinski; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

8.  Frequency of the Common MYH Mutations (G382D and Y165C) in MMR Mutation Positive and Negative HNPCC Patients.

Authors:  Katie A Ashton; Cliff J Meldrum; Mary L McPhillips; Carla F Kairupan; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2005-05-15       Impact factor: 2.857

9.  Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.

Authors:  Mala Pande; Christopher I Amos; Daniel R Osterwisch; Jinyun Chen; Patrick M Lynch; Russell Broaddus; Marsha L Frazier
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

Review 10.  Familial pancreatic cancer.

Authors:  Harald Rieder; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.